← Eichor
Study identifier: NCT06927362 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

LSVT Big and Dual Task Training in Cognitive Impaired Patients

Condition: Cognitive Impairment · Balance Changes · Cognition Disorders in Old Age  ·  Sponsor: Riphah International University

PhaseNA
Planned participants50
Who can joinAll sexes, 65 Years to no upper limit
Healthy volunteersNo

About this study

The goal of this study ifs to determine the comparative effects of Lee Silverman voice treatment Big and dual task training on balance, cognition and functional mobility in older adults with cognitive impairment. Perform LSVT big four times in a week for about 4 months. Perform dual task training four times in a week for about 4 months. Complete assessments at baseline, the 4th, 8th, 12th weeks, and a follow-up at the 16th week. Outcome measures include Mini BESTest, MoCA, stroop test and time up and go test. Statistical analyses will assess within-group and between-group effects based on data distribution.

This description comes directly from the study's public registry record.

Talk to the study team

Arooba Saeed, phD  ·  03344399403  ·  aruba.saeed@riphah.edu.pk

Rabia Aslam, MS(NMPT)  ·  03233337849  ·  drrabiaaslamdpt@gmail.com

Always discuss trial participation with your own doctor first.

Locations (1)

Iqra Medical Complex and Irtiqa Fitness ClubLahore, Punjab Province, PakistanRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06927362